Akoya Biosciences–JPMorgan Chase: investor conference, 202301 supply service Akoya presents at JP Morgan Healthcare Conference 2023

	Period	2023-01-11
	Region	San Francisco, CA
	Country	United States (USA)
	Partner, 1st	Akoya Biosciences Inc., Menlo Park
	Group	Akoya Biosciences (Group)
	Partner, 2nd	J.P. Morgan Securities LLC
	Group	JPMorgan Chase (Group)
	Product	J.P. Morgan 41st Annual Healthcare Conference 2023 San Francisco
	Person	McKelligon, Brian (Akoya Biosciences 201810 CEO)
	Person 2	Shah, Priyam (Akoya BIosciences 202212 Senior Director Investor Relations)

Akoya Biosciences, Inc.. (12/28/22). "Press Release: Akoya to Participate at 41st Annual J.P. Morgan Healthcare Conference". Marlborough, MA.

Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced that it will be participating in the 41st Annual J.P. Morgan Healthcare Conference.

Brian McKelligon, CEO, is scheduled to present on Wednesday, January 11th, 2023 at 9:45 a.m. PT.

A live and archived webcast of the event will be available on the “Investors” section of the Akoya website at https://investors.akoyabio.com/.

About Akoya Biosciences

As The Spatial Biology Company®, Akoya Biosciences’ mission is to bring context to the world of biology and human health through the power of spatial phenotyping. The company offers comprehensive single-cell imaging solutions that allow researchers to phenotype cells with spatial context and visualize how they organize and interact to influence disease progression and response to therapy. Akoya offers a full continuum of spatial phenotyping solutions to serve the diverse needs of researchers across discovery, translational and clinical research via its key platforms: PhenoCycler™, PhenoImager™ Fusion and PhenoImager HT. To learn more about Akoya, visit www.akoyabio.com.

Investor Contact:

Priyam Shah
Sr. Director, Investor Relations
Akoya Biosciences, Inc.
investors@akoyabio.com

Media Contact:

Christine Quern
(617) 650-8497
media@akoyabio.com